Amass Emerges From Stealth with Funding from Giant Ventures, Kost Capital and EIFO to offer AI for life sciences
COPENHAGEN, August 2025, Amass, the AI-native intelligence platform, just announced €1.4 million in pre-seed funding in a highly competitive round led by Giant Ventures, and joined by Kost Capital and Dr. Christian Thirion, founder and CEO of Sirion Biotech GmbH, acquired by Perkin Elmer, Dr. Christian Thirion, and EIFO, Danish Sovereign Wealth Fund - Denmark’s largest life science investor.
